Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Lung Neoplasms 2Liver Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Sarcoma 1Recurrence 1Precancerous Conditions 1Pharyngeal Neoplasms 1Peritoneal Neoplasms 1Paranasal Sinus Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Laryngeal Neoplasms 1Glioblastoma 1Colonic Neoplasms 1Breast Neoplasms 1Biomarker Change Linked to Breast Cancer 1

Interventions

toripalimab 5Cisplatin 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Heavy Ion Radiotherapy 3Gemcitabine 3anlotinib 2spartalizumab 1nedaplatin 1icotinib 1fludarabine phosphate 1fludarabine 1famitinib 1donafenib 1Vorinostat 1TP protocol 1Sodium Chloride 1SHR-1701 1Quality of Life 1Paclitaxel 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Interleukin-2 1Immunotherapy, Adoptive 1Gefitinib 1Cyclophosphamide 1Cetuximab 1Celecoxib 1Bevacizumab 1Adjuvants, Pharmaceutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Nasopharyngeal Carcinoma × Celecoxib × Clear all
NCT00212108 2012-04-02

A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839

National University Hospital, Singapore

Phase 1/2 Completed
22 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡